Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (002223.SZ)
CNY 35.85
(0.87%)
CNY 35.85
(0.87%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 2.2 Billion | 2.3 Billion | 1.2 Billion | 2.83 Billion | 614.2 Million | 798.14 Million |
| Net Income | 2.39 Billion | 1.57 Billion | 1.48 Billion | 1.75 Billion | 761.57 Million | 750.88 Million |
| Depreciation & Amortization | 254.81 Million | 222.38 Million | 202.47 Million | 161.01 Million | 96.28 Million | 90.64 Million |
| Deferred income taxes | 191.53 Million | -42.41 Million | -22.11 Million | -47.73 Million | 2.49 Million | -8 Million |
| Stock-based compensation | 21.08 Million | - | - | - | - | - |
| Change in working capital | -148.48 Million | 647.04 Million | -487.38 Million | 806.15 Million | -260.87 Million | -18.84 Million |
| Other non-cash items | 160.03 Million | -145.31 Million | 2.08 Million | 107.07 Million | 17.21 Million | -24.53 Million |
| Investing Cash Flow | 1.66 Billion | -417.89 Million | -1.82 Billion | -1.55 Billion | -553.16 Million | -1.06 Billion |
| Investments in PPE | -132.57 Million | -379.37 Million | -284.32 Million | -678.91 Million | -440.38 Million | -389.54 Million |
| Acquisitions | 17.44 Million | -81.54 Million | -318.37 Million | 111.47 Million | 490.03 Thousand | - |
| Investment purchases | -2.07 Billion | -10.83 Billion | -10.34 Billion | -7.65 Billion | -4.98 Billion | -4.87 Billion |
| Sales/Maturities of investments | 3.84 Billion | 10.67 Billion | 8.63 Billion | 6.71 Billion | 4.87 Billion | 4.19 Billion |
| Other Investing Activities | 15.79 Million | 198.59 Million | 485.26 Million | -49.24 Million | 529.98 Thousand | 5.27 Million |
| Financing Cash Flow | -1.46 Billion | 354.89 Million | 774.7 Million | -453.66 Million | -166.19 Million | -146.86 Million |
| Debt repayment | -913.36 Million | -49.09 Million | -654.39 Million | -1.48 Billion | -163.46 Million | -170.26 Million |
| Dividends payments | -597.74 Million | -298.87 Million | -297.03 Million | -400.99 Million | -150.37 Million | -155.8 Million |
| Common Stock Repurchased | - | -14.96 Million | -349.97 Million | - | - | - |
| Common Stock Issuance | - | 14.96 Million | 149 Million | - | - | - |
| Other Financing Activities | 42.95 Million | 754.79 Million | 1.94 Billion | 1.44 Billion | 156.52 Million | 179.2 Million |
| Accounts receivables | 169.43 Million | 95.12 Million | 308.95 Million | 614.48 Million | -230.8 Million | -85.66 Million |
| Accounts payables | -375.6 Million | 853.76 Million | -471.41 Million | 361.82 Million | 239.35 Million | 98.05 Million |
| Inventory | 62.71 Million | -259.43 Million | -302.8 Million | -122.42 Million | -271.91 Million | -23.23 Million |
| Other working capital | -5.02 Million | -42.41 Million | -22.11 Million | -47.73 Million | 2.49 Million | 4.38 Million |
| Cash at beginning of period | 4.83 Billion | 2.38 Billion | 2.26 Billion | 1.56 Billion | 1.66 Billion | 2.05 Billion |
| Cash at end of period | 7.21 Billion | 4.76 Billion | 2.38 Billion | 2.26 Billion | 1.56 Billion | 1.66 Billion |
| Capital Expenditure | -132.57 Million | -379.37 Million | -284.32 Million | -678.91 Million | -440.38 Million | -389.54 Million |
| Effect of forex changes on cash | 24.2 Million | 136.08 Million | -27.82 Million | -112.76 Million | 7.1 Million | 22.71 Million |
| Net cash flow / Change in cash | 2.37 Billion | 2.37 Billion | 119.36 Million | 706.12 Million | -98.05 Million | -392.23 Million |
| Free Cash Flow | 2.06 Billion | 1.92 Billion | 916.87 Million | 2.15 Billion | 173.81 Million | 408.6 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 411.39 Million | 460.78 Million | 659.41 Million | 205.17 Million | 2.39 Billion | 696.66 Million |
| Depreciation & Amortization | - | 64.28 Million | 64.28 Million | 64.85 Million | 254.81 Million | 64.85 Million |
| Deferred income taxes | 5.75 Million | - | - | - | 191.53 Million | - |
| Stock-based compensation | - | 13.23 Million | - | 21.08 Million | 21.08 Million | - |
| Change in working capital | - | -283.02 Million | - | 227.12 Million | -148.48 Million | - |
| Other non-cash items | -48.22 Million | -58.57 Million | 16.19 Million | 252.4 Million | 160.03 Million | -449.83 Million |
| Investing Cash Flow | -31.24 Million | 161.73 Million | -28.35 Million | 130.18 Million | 1.66 Billion | 1.35 Billion |
| Investments in PPE | -21.67 Million | -20.63 Million | -21.47 Million | -33.68 Million | -132.57 Million | -25.83 Million |
| Acquisitions | 2.39 Million | 64.1 Thousand | - | 1.72 Million | 17.44 Million | 16.66 Million |
| Investment purchases | -22.53 Million | 23.85 Thousand | -109.24 Million | -301.86 Million | -2.07 Billion | -96.12 Million |
| Sales/Maturities of investments | 10.56 Million | 182.27 Million | 99.52 Million | 480.79 Million | 3.84 Billion | 1.45 Billion |
| Other Investing Activities | 1561.70 | 87.76 Million | 2.83 Million | -16.78 Million | 15.79 Million | 18.39 Thousand |
| Financing Cash Flow | -186.26 Million | -1.59 Billion | -199.51 Million | 64.32 Million | -1.46 Billion | 66.52 Million |
| Debt repayment | -200 Million | -782.13 Million | -200 Million | -27.2 Million | -913.36 Million | - |
| Dividends payments | -801.6 Million | -801.6 Million | -12.34 Million | -597.74 Million | -597.74 Million | -13.79 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -787.86 Million | -10.15 Million | 484.48 Thousand | 689.27 Million | 42.95 Million | 80.31 Million |
| Accounts receivables | - | -380.16 Million | - | 169.43 Million | 169.43 Million | - |
| Accounts payables | - | - | - | - | -375.6 Million | - |
| Inventory | - | 83.9 Million | - | 62.71 Million | 62.71 Million | - |
| Other working capital | - | 13.23 Million | - | -5.02 Million | -5.02 Million | - |
| Cash at beginning of period | 6.56 Billion | 7.64 Billion | 7.21 Billion | 6.63 Billion | 4.83 Billion | 4.93 Billion |
| Cash at end of period | 6.68 Billion | 6.56 Billion | 7.64 Billion | 7.21 Billion | 7.21 Billion | 6.59 Billion |
| Capital Expenditure | -21.67 Million | -20.63 Million | -21.47 Million | -33.68 Million | -132.57 Million | -25.83 Million |
| Effect of forex changes on cash | - | 5.28 Million | 633.88 Thousand | 6.5 Million | 24.2 Million | -7.68 Million |
| Net cash flow / Change in cash | 115.21 Million | -1.08 Billion | 432.7 Million | 583.25 Million | 2.37 Billion | 1.65 Billion |
| Free Cash Flow | 347.25 Million | 317.29 Million | 654.13 Million | 359.04 Million | 2.06 Billion | 220.99 Million |
4486
KALD
NEWTZ
CML
6750
JRSH